This is the text extract for Tender Results, browse documents here.

---

31 July 2009

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th August 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 September 2009, reference pricing of nontender winning brand will occur on 1 November 2009 and Sole Subsidised Supply commences on 1 February 2010.

The decisions were as follows:

Chemical Name Isotretinoin Isotretinoin

Presentation; Pack size and type Cap 10 mg; 180 tablets, blister

Current subsidy

$36.00 (100 tablets) $47.50 Cap 20 mg; 180 tablets, blister (100 tablets)

New tender subsidy $48.48 (180 tablets) $69.70 (180 tablets)

Sole supply brand (Supplier) Oratane (Douglas) Oratane (Douglas)

Brands affected by reference pricing and delisting Isotane 10 (Mylan) Isotane 20 (Mylan)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 September 2009; DV Limits and DV pharmaceuticals will apply from 1 November 2009; de-listing of other brands in Section H will occur on 1 November 2009.

Presentation; Pack size and type Hospital Supply Brand (Supplier) Pack Price DV Limit DV Pharmaceuticals Brand Name (Supplier) Acihexal (Novartis) Hospira (Hospira) Aciclovir Inj 250 mg; 5 injections, ampoule Pfizer (Pfizer) $25.50 1% Lovir (Douglas) m-Aciclovir (Multichem) Zovirax (GSK)

Chemical Name

A297094 - qA12214

---

DV Pharmaceuticals Chemical Name Presentation; Pack size and type Hospital Supply Brand (Supplier) Pack Price DV Limit Brand Name (Supplier) Hibitane (AFT) Chlorhexidine Crm 1% obstetric; 50 g, tube healthE (Jaychem) $1.36 1% Orion (Orion) PSM (PSM) Isotretinoin Cap 10 mg; 180 tablets, blister Oratane (Douglas) $48.48 1% Isotane 10 (Pacific) Roaccutane (Roche) Isotane 20 (Pacific) Roaccutane (Roche) Orion (Orion) Mayne (Hospira) Mayne (Hospira)

Isotretinoin Lignocaine Ondansetron hydrochloride Ondansetron hydrochloride

Cap 20 mg; 180 tablets, blister Gel 2%; 30 ml, tube Inj 2 mg per ml, 2 ml; 5 injections, amopoule Inj 2 mg per ml, 4 ml; 5, injections, ampoule

Oratane (Douglas) Xylocaine Jelly (AstraZeneca) Zofran Zofran

$69.70 $6.00 $14.40 $23.20

1% 1% 1% 1%

3. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 September 2009 and DV Limits and DV Pharmaceuticals will apply from 1 November 2009.

The decisions were as follows:

Chemical Name Baclofen Caspofungin Caspofungin Hydroxyethyl starch 130/0.4

Presentation; Pack size and type Inj 10 mg; 1 injection, ampoule Inj 50 mg; 1 injection, vial Inj 70 mg; 1 injection, vial, Inj 6%; 20 injections, bag

Hospital Supply Brand (Supplier)

Pack Price

DV Limit 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) (B) (B) Venofundin 6% (B Braun)

Lioresal Intrathecal $190.08 (Novartis) Cancidas (MSD) Cancidas (MSD) $667.50 $862.50

Voluven (Pharmatel $198.00 Fresenius Kabi)

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.

The decisions were as follows:

Chemical Name Acetylcholine Amikacin Amikacin Amoxycillin Amphotericin B Amphotericin B Apomorphine Hydrochloride Apomorphine Hydrochloride Arginine Atropine Sulphate

Line Item Inj 10 mg per ml, 2 ml Inj 5 mg per ml, 5 ml Inj 250 mg per ml, 2 ml Grans for oral liq 125 mg per 5 ml Emulsion for infusion 5 mg per ml Inj 50 mg Inj 10 mg per ml, 1 ml Inj 10 mg per ml, 2 ml Inj 5%, 500 ml Inj 400 mcg, 1 ml

A297094 - qA12214

Page 2 of 5

---

Chemical Name Atropine Sulphate Baclofen Baclofen Beractant Betahistine Dihydrochloride Bleomycin sulphate Betaxolol Hydrochloride Betaxolol Hydrochloride Budesonide Budesonide Budesonide Budesonide Capecitabine Capecitabine Carboplatin Carmustine Celiprolol Chloroquine Chloroquine Ciprofloxacin Clindamycin Clobetasol Propionate Clobetasol Propionate Dacarbazine Dacarbazine Danazol Danazol Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosphate Diazepam Diazepam Diclofenac Sodium Dicloxacillin Dobutamine Doxorubicin Enalapril With Hydrochlorothiazide Ephedrine Sulphate Ergometrine Maleate Ergotamine Tartrate with Caffeine Etoposide Etoposide Etoposide Phosphate Gentamicin Sulphate Glyceryl Trinitrate Glyceryl Trinitrate Glycopyrronium Glycopyrronium Hydralazine Hydrocortisone

Line Item Inj 1200 mcg, 1 ml Oral liq 5 mg per 5 ml Tab 20 mg Inj 25 mg per ml, 8 ml Tab 16 mg Inj 15,000 iu Eye drops 0.25% Eye drops 0.5% Metered aqueous nasal spray, 50 mcg per dose Metered aqueous nasal spray, 100 mcg per dose Nebuliser soln, 500 mcg per ml, 2 ml Nebuliser soln, 1 mg per ml, 2 ml Tab 150 mg Tab 500 mg Inj 10 mg per ml, 10 ml Inj 100 mg, 3 ml Tab 200 mg Oral liq Tab 200 mg - 250 mg Eye Drops 0.3% Inj phosphate 150 mg per ml, 4 ml Crm 0.05% (pack size greater than 30 g) Oint 0.05% (pack size greater than 30 g) Inj 50 mg Inj 200 mg Cap 100 mg Cap 200 mg Inj 4 mg per ml, 1 ml Inj 4 mg per ml, 2 ml Rectal tubes 5 mg Rectal tubes 10 mg Cap long-acting 100 mg Inj 500 mg Inj 12.5 mg per ml, 20 ml Inj 20 mg Tab 20 mg with hydrochlorothiazide 12.5 mg Inj 30 mg per ml, 1 ml Inj 500 mcg per ml, 1 ml Tab 1 mg with caffeine 100 mg Cap 50 mg Cap 100 mg Inj 100 mg (of etoposide base) Inj 10 mg per ml, 1 ml Inj 5 mg per ml, 1 ml Inj 5 mg per ml, 10 ml Inj 0.2 mg per ml, 1 ml Inj 500 mcg with 2.5 mg neostigmine per ml, 1 ml Inj 20 mg per ml, 1 ml Crm 1% (pack size 15 g or less)

A297094 - qA12214

Page 3 of 5

---

Chemical Name Hydrocortisone Hydrocortisone Imipramine Hydrochloride Imipramine Hydrochloride Lansoprazole Lansoprazole Lansoprazole Lorazepam Lorazepam Magnesium Sulphate Maprotiline Hydrochloride Maprotiline Hydrochloride Metaraminol Tartrate Methotrexate Methotrexate Metoclopramide Hydrochloride with Paracetamol Miconazole Midazolam Milrinone Mometasone Furoate Morphine Sulphate Morphine Sulphate Morphine Sulphate Morphine Sulphate Morphine Sulphate Morphine Sulphate Morphine Sulphate Morphine Tartrate Morphine Tartrate Mucilaginous Laxatives Mupirocin Naproxen Naproxen Naproxen Sodium Nicotinic Acid Nicotinic Acid Nicotinic Acid Nicotinic Acid Nicotinic Acid Oestrogens Paracetamol Paracetamol Paracetamol Paracetamol Paracetamol Pethidine Hydrochloride Pethidine Hydrochloride Pethidine Hydrochloride Phenindione

Line Item Crm 1% (pack size greater than 15 g and 100 g or less) Inj 50 mg per ml, 2 ml Tab 10 mg Tab 25 mg Cap 15 mg Cap 30 mg Inj 40 mg Inj 4 mg per ml, 1 ml Tab 0.5 mg Inj 49.3%, 5 ml Tab 25 mg Tab 75 mg Inj 1 mg per ml, 10 ml prefilled syringe Inj 25 mg per ml, 2 ml Inj 25 mg per ml, 20 ml Tab 5 mg with paracetamol 500 mg Oral gel 20 mg per g Tab 7.5 mg Inj 1 mg per ml, 10 ml Lotn 0.1% Inj 5 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Tab long-acting 10 mg Tab long-acting 30 mg Tab long-acting 60 mg Tab long-acting 100 mg Tab long-acting 200 mg Inj 80 mg per ml, 1.5 ml Inj 80 mg per ml, 5 ml Dry Nasal oint 2% Tab EC 250 mg Tab EC 500 mg Tab 550 mg Tab 25 mg Tab 50 mg Tab 100 mg Tab modified-release 500 mgNicotinic Acid Tab modified-release 1 g Conjugated, equine tab 300 mcg Inj 10 mg per ml, 50 ml Inj 10 mg per ml, 100 ml Suppos 125 mg Suppos 250 mg Tab modified-release Inj 50 mg per ml, 1 ml Inj 50 mg per ml, 1.5 ml Inj 50 mg per ml, 2 ml Tab 10 mg

A297094 - qA12214

Page 4 of 5

---

Chemical Name Phenindione Phenindione Phenoxybenzamine Potassium Chloride Pyridoxine Hydrochloride Quinine Sulphate Rasburicase Sodium Bicarbonate Sodium Chloride Sodium Chloride Sodium Chloride Sodium Hyaluronidate Stavudine (d4T) Streptomycin Tenoxicam Tenoxicam Testosterone Tetrabenazine Tetracycline Hydrochloride Thiamine Hydrochloride Ticarcillin Ticarcillin Urea Vecuronium Vecuronium

Line Item Tab 25 mg Tab 50 mg Inj 100 mg per 2 ml Oral suspension Tab 50 mg Tab 200 mg Inj 1.5 mg Inj 8.4% 10 ml Inj 0.9%, 5 ml Inj 0.9%, 10 ml Inj 0.9%, 20 ml Inj 14 mg per ml Cap 30 mg Inj 1 g Inj 10 mg per ml, 2 ml Tab 20 mg Transdermal patch 2.5 mg per day Tab 25 mg Cap 250 mg Inj 100 mg per ml, 2 ml Inj 1 g Inj 3 g Crm 10% Inj 4 mg Inj 10 mg

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A297094 - qA12214

Page 5 of 5